Development of a clinical chemiluminescent immunoassay for serum GPC3 and simultaneous measurements alone with AFP and CK19 in diagnosis of hepatocellular carcinoma.

Abstract

BACKGROUND:

Glypican-3 (GPC3) is an oncofetal antigen that shows great promise as a biomarker for diagnosis of hepatocellular carcinoma (HCC), but there is no reliable kit that can be used to detect it in clinics. The aim of this study is to develop a stable performance kit for GPC3 detection in clinics.

DESIGN AND METHODS:

The paired antibodies were identified through cycle-screening methods based on our previous research. Then, a double antibodies sandwich chemiluminescent immunoassay for detecting serum GPC3 was developed. The performance of the developed GPC3 diagnostic kit was evaluated by detecting the concentration of serum GPC3 and assessing its single or combined use with alpha fetoprotein (AFP) and cytokeratin 19 fragment (CK19) for HCC diagnosis.

RESULTS:

The assay demonstrated a linear range of 10-800 ng/ml, the cross-reactivity rate at 0.018% (AFP), 0.020% (carcino-embryonic antigen), and 0.021% (CK19), respectively. The minimum detectable concentration was 0.05 ng/ml; the intraassay coefficient of variation (CV) and interassay CV were both less than 10%, with good stability and reproducibility. GPC3 has a high sensitivity (54.2%) and specificity (99.4%) in diagnosing HCC. The level of GPC3 in HCC was robust higher than that in healthy or other liver diseases' sera (108.67 ± 230.04 ng/ml vs. 3.99 ± 7.68 ng/ml). The diagnostic sensitivity of GPC3 single or combined with CK19 and AFP for HCC was evaluated, and the rates were 54.2 and 90.6%, respectively.

CONCLUSIONS:

An applicable chemiluminescent immunoassay with stable performance against GPC3 in diagnosing HCC has been established and the combination of GPC3 with CK19 and AFP could improve the diagnostic sensitivity for HCC.

• Authors: Juan-Ping Yu, Xi-Guang Xu, Rui-Juan Ma, Shi-Ni Qin, Cong-Rong Wang, Xiao-Bo Wang, Ming Li, Ming-Song Li, Qiang Ma, Wei-Wen Xu
• Journal: Journal of clinical laboratory analysis (J Clin Lab Anal) Vol. 29 Issue 2 Pg. 85-93 (Mar 2015) ISSN: 1098-2825 [Electronic] United States
• PMID: 24687454 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © 2014 Wiley Periodicals, Inc.

Chemical References

• Biomarkers, Tumor
• GPC3 protein, human
• Glypicans
• Keratin-19
• alpha-Fetoproteins

Topics

• Biomarkers, Tumor (blood)
• Carcinoma, Hepatocellular (blood)
• Glypicans (blood)
• Humans
• Immunoassay (methods)
• Keratin-19 (blood)
• Liver Neoplasms (blood)
• Luminescent Measurements (methods)
• Reproducibility of Results
• Sensitivity and Specificity
• alpha-Fetoproteins (analysis)